Carregant...

Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancer

Context: Focal adhesion kinase (FAK) and Src are overexpressed and activated in many cancers and have been associated with tumor progression. The role of the Src-FAK complex has not been characterized in papillary and anaplastic thyroid cancer (PTC and ATC). Objective: The goal of this study was to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schweppe, Rebecca E., Kerege, Anna A., French, Jena D., Sharma, Vibha, Grzywa, Rachel L., Haugen, Bryan R.
Format: Artigo
Idioma:Inglês
Publicat: The Endocrine Society 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2690419/
https://ncbi.nlm.nih.gov/pubmed/19293266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2008-2511
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!